Clinical Trials Directory

Trials / Unknown

UnknownNCT01988545

GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow

GLP-1's Influence on Intestinal Blood Flow

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
8 (estimated)
Sponsor
Zealand University Hospital · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Accepted

Summary

to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters

Detailed description

to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters, in healthy subjects, 4 arms, task force monitor

Conditions

Interventions

TypeNameDescription
OTHER1,5 nmol/kg,GLP-1 sc injection
OTHER1,5 nmol/kg GLP-1 9-36amide, sc injection
OTHERExendin-4 ;10 ug,sc injection
OTHERsaline

Timeline

Start date
2013-11-01
Primary completion
2014-06-01
Completion
2014-12-01
First posted
2013-11-20
Last updated
2013-11-20

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01988545. Inclusion in this directory is not an endorsement.

GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow (NCT01988545) · Clinical Trials Directory